Trial Profile
Pharmacokinetic and Pharmacodynamic Bioequivalence of Single Dose Zydus pegfilgrastim to Neulasta pegfilgrastim from US and EU Sources - NIL
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Pharmacokinetics
- Sponsors Zydus Lifesciences
- 30 May 2017 New trial record